Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AERI

Aerie Pharmaceuticals (AERI) Stock Price, News & Analysis

Aerie Pharmaceuticals logo

About Aerie Pharmaceuticals Stock (NASDAQ:AERI)

Key Stats

Today's Range
$15.25
$15.25
50-Day Range
$15.18
$15.25
52-Week Range
$4.81
$15.37
Volume
600 shs
Average Volume
974,748 shs
Market Capitalization
$753.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AERI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aerie Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AERI Stock News Headlines

October 16 Changes the Microchip Game — and Investing
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology.tc pixel
20 Countries With Worst Vision Problems
See More Headlines

AERI Stock Analysis - Frequently Asked Questions

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) issued its earnings results on Thursday, November, 4th. The company reported ($0.72) earnings per share for the quarter, missing the consensus estimate of ($0.62) by $0.10. The firm had revenue of $29.31 million for the quarter, compared to analyst estimates of $29.13 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aerie Pharmaceuticals investors own include Canopy Growth (CGC), Nicox (NICXF), Bristol Myers Squibb (BMY), Meta Platforms (META), NVIDIA (NVDA), Pfizer (PFE) and Melinta Therapeutics (MLNT).

Company Calendar

Last Earnings
11/04/2021
Today
10/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:AERI
CIK
1337553
Employees
376
Year Founded
2005

Profitability

EPS (Trailing Twelve Months)
($0.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$74.81 million
Net Margins
-17.09%
Pretax Margin
-16.47%
Return on Equity
N/A
Return on Assets
-2.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.27
Quick Ratio
1.92

Sales & Book Value

Annual Sales
$194.13 million
Price / Sales
3.88
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($3.32) per share
Price / Book
-4.59

Miscellaneous

Outstanding Shares
49,417,000
Free Float
47,223,000
Market Cap
$753.61 million
Optionable
Optionable
Beta
-0.06

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:AERI) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners